Company Spotlight: Imvaria Fibresolve - AI for Lung Fibrosis with a Built-In Update Plan

Podcast: AI in Medicine - curated summaries making complex issues easy to understand · Mike Rawson

Opublikowano: 2026-11-03

We unpack the FDA 510(k) summary for Imvaria's Fibresolve with PCCP. This software-only device analyzes lung CT scans as an adjunct for diagnosing idiopathic pulmonary fibrosis prior to invasive testing. We explore how its Predetermined Change Control Plan allows the manufacturer to update and re-train the AI model over time without requiring new regulatory clearance. Key points Fibresolve is a Class II software-only device that uses an ensemble 3D deep learning model to analyze DICOM-compliant lung CT scans for suspected interstitial lung disease.It acts as an adjunct in the diagnosis of idiopathic pulmonary fibrosis (IPF...